WO2008040463A1 - Préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de l'acide (r)-2-[((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-propionique et une ou plusieurs matières de charge - Google Patents

Préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de l'acide (r)-2-[((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-propionique et une ou plusieurs matières de charge Download PDF

Info

Publication number
WO2008040463A1
WO2008040463A1 PCT/EP2007/008236 EP2007008236W WO2008040463A1 WO 2008040463 A1 WO2008040463 A1 WO 2008040463A1 EP 2007008236 W EP2007008236 W EP 2007008236W WO 2008040463 A1 WO2008040463 A1 WO 2008040463A1
Authority
WO
WIPO (PCT)
Prior art keywords
preparations
fillers
cosmetic
isopropyl
weight
Prior art date
Application number
PCT/EP2007/008236
Other languages
German (de)
English (en)
Inventor
Julia Eckert
Ludger Kolbe
Gitta Neufang
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of WO2008040463A1 publication Critical patent/WO2008040463A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24Thermal properties
    • A61K2800/244Endothermic; Cooling; Cooling sensation

Definitions

  • the present invention relates to cosmetic or dermatological preparations containing 2-isopropyl-5-methyl-cyclohexanecarbonyl-D-alanine methyl ester (synonymous (R ⁇ - ⁇ IR ⁇ S.SR ⁇ -isopropyl- ⁇ -methyl-cyclohexanecarbonyO-aminol-propionic acid methyl ester and one or more fillers.
  • the present invention relates, in a particular embodiment, to cosmetic or pharmaceutical preparations with a reduced tack feeling, processes for their preparation and the use of active ingredients for reducing the stickiness of cosmetic preparations.
  • the present invention relates to cosmetic and dermatological preparations with a long-lasting cooling effect, in particular skin-care cosmetic and dermatological preparations.
  • cooling agents in particular ammonium salts
  • cooling preparations are also widely used isopropanolic gels with camphor and menthol additive.
  • a further object of the present invention was to provide preparations which markedly improve the condition of the skin, in particular reduce skin roughness.
  • an object of the present invention to provide products with the widest possible variety of applications available.
  • principles should be created for preparation forms such as cleansing emulsions, face and body care preparations, but also pronounced medical-pharmaceutical dosage forms, for example preparations for acne and other skin conditions.
  • Preparations according to the invention are distinguished by outstanding, pleasant cooling effect and elegant cosmetic appearance. They are not unpleasantly sticky and sta- bil against physical decomposition such as up or down frame their constituents.
  • Fillers in the context of the present invention are particulate substances which as a rule do not produce any color effect in the cosmetic formulation in which they are used. Furthermore, fillers according to the invention usually have a low refractive index and, as a result, no or very little opacity.
  • the prior art knows a number of fillers, which z. B. serve as support materials in the formulation of powders or as viscosity and sensor modulators in emulsions or anhydrous formulations. Such fillers are also often used to obtain matting effects on the skin or to absorb sebum.
  • fillers generally also affects the spreadability of conventional formulations on the skin and the uniformity of a possible color effect.
  • the fillers in the context of the present invention are advantageously selected from the group of inorganic fillers, for example from the group of silicates.
  • Silicates are salts and esters (silicic acid esters) of orthosilicic acid [Si (OH) 4 ] and their condensation products.
  • the silicates are not only the most species-rich class of minerals, but also extremely important geologically and technically. Over 80% of the earth's crust is made up of silicates.
  • leaf silicates are (ideally) silicate structures with two-dimensionally infinite layers of [SiO 4 ] 4 ⁇ tetrahedra, each tetrahedron being connected via 3 bridging oxygens to neighboring tetrahedra.
  • Chemical formulas can only be approximated for phyllosilicates because they have a large ion exchange capacity and silicon can be exchanged for aluminum and this in turn against magnesium, Fe 2+ , Fe 3+ , Zn and the like.
  • the resulting possibly negative charge of the layers is usually compensated by cations, in particular by Na + and Ca 2+ in interlayer positions.
  • Phyllosilicates can be obtained by reversible storage of water (in the 2- to 7-fold amount) and other substances such. As alcohols, glycols and the like swell. Their use as thickeners in cosmetic products is accordingly known per se. However, the prior art could not point the way to the present invention.
  • Advantageous phyllosilicates which can be used in the context of the present invention are, for example, those whose largest expansion direction in the unmodified and unswollen state has on average a length of less than 10 ⁇ m.
  • the mean extents of the modified layered silicate particles used may be 1000 nm ⁇ 100 nm ⁇ 1 nm and less.
  • the effective size of the modified layered silicate particles in a cosmetic or dermatological formulation of course depends on the amount of stored substances.
  • Particularly advantageous (layered) silicates according to the invention are:
  • Bentonite montmorillonite with Ca (filler earth) or Na (Wyoming bentonite)
  • Mica an aluminosilicate that is easily fissile and is present in tabular crystals. Mica is transparent to translucent and has pearlescence. The most important form is muscovite: K AI 2 [AISi 3 O 10 ] (OH, F) 2 . Sericite is a special form of mica that has smaller platelets than muscovite.
  • silicon oxides SiO 2
  • Aerosils fumed silica
  • Aerosils which are highly disperse silicas with frequently irregular shape, whose specific surface area is generally very large (200-400 m 2 / g) and which can be controlled by means of the production process, are preferred according to the invention. Aerosils are also referred to as: Amorphous Silica Amorphous Silicon Oxide Hydrate Silica, Amorphous Silicic Anhydride Silicon Dioxide Silicon Dioxide.
  • Aerosil 130 (Degussa Huls), Aerosil 200 (Degussa Huls), Aerosil 255 (Degussa Huls), Aerosil 300 (Degussa Huls), Aerosil 380 (Degussa Huls), B-6C (Suzuki Yushi), CAB-O-SIL Fumed Silica (Cabot), CAB-O-SIL EH-5 (Cabot), CAB-O-SIL HS-5 (Cabot), CAB-O-SIL LM-130 (Cab bot), CAB-O-SIL MS-55 (Cabot), CAB-O-SIL M-5 (Cabot), E-6C (Suzuki Yushi), Fossil Flour MBK (MBK), MSS-500 (Kobo), Neosil CT 1 1 (Crosfield Co.), Ronasphere (Rona / EM Industries), Silica, Anhydrous 31 (Whittaker, Clark & Daniels), Silica, Crystalline
  • Silicon oxides can also be produced in a spherical form, in which case the specific surface area is smaller than in the aerosils, since the particles are larger and round.
  • An example of this is the Ronaspheren (average particle diameter ⁇ 3 ⁇ ) from the company Merck.
  • Further fillers preferred according to the invention are silicas whose free OH groups on the particle surface are (completely or partially) organically modified.
  • the obtainable by addition of dimethylsilyl groups silica dimethyl silylates such as Aerosil R972 (Degussa Hüls), Aerosil R974 (Degussa Hüls), CAB-O-SIL TS-610 (Cabot), CAB-O-SIL TS -720 (Cabot), Wacker HDK H15 (Wacker chemistry), Wacker HDK H18 (Wacker chemistry) and / or Wacker HDK H20 (Wacker chemistry).
  • dimethylsilyl groups silica dimethyl silylates such as Aerosil R972 (Degussa Hüls), Aerosil R974 (Degussa Hggs), CAB-O-SIL TS-610 (Cabot), CAB-O-SIL TS -720 (Cabot), Wacker HDK H15 (Wacker chemistry), Wacker HDK H18 (Wacker chemistry) and / or Wacker HDK H20 (Wacker chemistry).
  • silicates obtainable by addition of trimethylsilyl groups (eg Aerosil R 812 (Degussa Hüls), CAB-O-SIL TS-530 (Cabot), Sipemat D 17 (Degussa Hüls), Wacker HDK H2000 (Wacker). Chemistry)).
  • trimethylsilyl groups eg Aerosil R 812 (Degussa Hüls), CAB-O-SIL TS-530 (Cabot), Sipemat D 17 (Degussa Hüls), Wacker HDK H2000 (Wacker). Chemistry
  • polymethylsilsesquioxanes obtainable by hydrolysis and condensation reactions of methyltrimethoxysilanes, which likewise have a round shape and whose particle size distribution can be controlled by the preparation.
  • Preferred polymethylsilsesquioxanes are available, for example, under the trade names Tospearl 2000 B from GE Bayer Silikones, Tospearl 145A from Toshiba, AEC Silicone Resin Spheres from A & E Connock and Wacker-Belsil PMS MK from Wacker-Chemie.
  • Boron nitride is isoelectronic with carbon (i.e., graphite and diamond shapes are possible). Boron nitride is characterized by its chemical inertness.
  • fillers in the context of the present invention are carbonates, such as. As magnesium carbonate (MgCO 3 ) and calcium carbonate (CaCO 3 ). It is particularly advantageous for the purposes of the present invention to use the carbonates as fillers in dry powders.
  • MgCO 3 magnesium carbonate
  • CaCO 3 calcium carbonate
  • the fillers in the context of the present invention are also advantageously selected from the group of organic fillers.
  • advantageous organic fillers are, for.
  • natural polymers such as silk powder, microcrystalline cellulose and / or zinc stearates.
  • Advantageous organic fillers are also starch and starch derivatives, such as: corn starch Zea Mays (Amidone De Mais MST (Wackherr), Argo Brand Com Starch (Com Products), Pure-Dent (Grain Processing), Purity 21 C (National Starch)) .
  • Organic fillers preferred according to the invention are also synthetic polymers, ie. H. Polymer particles which are present in the preparation in the form of solids, such as polycarbonates, polyethers, polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyamides, polyurethanes, polyacrylates and the like. Particularly advantageous is z.
  • nylon polyamide 6 and polyamide 12
  • polyamide 6 for example microfine polyamide particles, in particular those available under the trade name SP-500 from TORAY.
  • polyamide 6 also: nylon 6
  • polyamide 12 also: nylon 12
  • Polyamide 6 is the polyamide [poly ( ⁇ -caprolactam)] synthesized from ⁇ -aminocaproic acid (6-aminohexanoic acid) or ⁇ -caprolactam
  • polyamide 12 is a poly ( ⁇ -laurinlactam) from ⁇ -laurolactam.
  • Advantageous for the purposes of the present invention are, for example Orgasol ® 1002 (polyamide 6), and Orgasol ® 2002 (polyamide 12) from ELF ATOCHEM.
  • Silicone Resins Trimethylsiloxysilicate (eg SR 1000 GE Bayer Silicones)
  • silicone elastomers can be selected from the group of vinyl dimethicone crosspolymers, such as. Dow Corning 9506 Cos- metic Powder from Dow Coming (INCI: Dimethicone / Vinyl Dimethicone Crosspolymer).
  • silicone resins such as e.g. KSP-100, KSP-200 or KSP-300 from Shin Etsu, which are also listed under the INCI name Dimethicone / Vinyl Dimethicone Crosspolymer or SR 1000 from GE Bayer Silicones, which bears the INCI name Trimethylsiloxy Silicate
  • lauroyl lysine which is sold by Ajinomoto under the name Amihope LL.
  • the total amount of at least one filler in the finished cosmetic or dermatological preparations is advantageously selected from the range of 0.05-20.0% by weight, preferably 0.5-10.0% by weight, based on the total weight of the preparations.
  • Fillers preferred according to the invention come from the group of inorganic or organic silicon compounds.
  • the layer silicates are particularly preferred. Of these, kaolin, talc and mica are particularly preferred.
  • the preferred inorganic silicon compounds include the organically modified spherical particles on the surface.
  • Aerosil R 972 particularly preferred are the polymethylsilsesquioxanes and hydrophobically modified aerosils, e.g. Aerosil R 972.
  • Organic silicon compounds include the siloxane elastomers and siloxane resins. Of these, particularly preferred are the KSP types from Shin Etsu, as well as the trimethylsiloxysilicate. Further inventively preferred fillers come from the group of spherical particles. More preferably, the average particle diameter is less than 20 microns. Furthermore, preference is given to choosing spherical particles of organic origin. Particularly preferred is the BPD-500 marketed by Kobo.
  • spherical particles having an average particle diameter of less than 10 ⁇ m are preferred.
  • nylon-12 e.g. sold as SP-501 or SP-500 by the company Kobo.
  • polymethyl methacrylates e.g. sold under the trade name Covabead LH 85 by LCW.
  • the preparations are characterized in that they contain 0.001% by weight to 10% by weight, preferably 0.05% by weight to 5% by weight, in particular 0.1-2, 0 wt .-%, based on the total weight of the preparations, on one or more fillers.
  • the cosmetic or dermatological preparations may be composed as usual and used for the treatment, care and cleansing of the skin and / or the hair and as a make-up product in decorative cosmetics.
  • They preferably contain from 0.001% by weight to 10% by weight, preferably from 0.05% by weight to 5% by weight, in particular from 0.1% to 2.0% by weight, based on the total weight of the preparations, 2-isopropyl-5-methylcyclohexanecarbonyl-D-alanine methyl ester.
  • Cosmetic and dermatological preparations according to the invention can be present in various forms.
  • they may contain a solution, an anhydrous preparation, an emulsion or microemulsion of the water-in-oil (W / O) type or of the oil-in-water (O / W) type, a multiple emulsion, for example water-type. in-oil-in-water (W / O / W), a gel, a solid stick, an ointment or even an aerosol.
  • folic acid and / or its derivatives in encapsulated form, for example in collagen matrices and other customary encapsulating materials, for example as encapsulated encapsulations, in gelatin, wax matrices or liposomally encapsulated.
  • encapsulated encapsulations for example in collagen matrices and other customary encapsulating materials, for example as encapsulated encapsulations, in gelatin, wax matrices or liposomally encapsulated.
  • Wax matrices as described in DE-OS 43 08 282 have been found to be favorable.
  • folic acid and / or derivatives thereof are also possible and advantageous for the purposes of the present invention to incorporate folic acid and / or derivatives thereof into aqueous systems or surfactant preparations for cleaning the skin and hair.
  • the cosmetic and dermatological preparations according to the invention may comprise cosmetic adjuvants such as are conventionally used in such preparations, e.g. Preservatives, bactericides, perfumes, foaming inhibitors, colorants, pigments having a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moistening and / or moisturizing substances, fats, oils, waxes or other conventional ingredients of a cosmetic or cosmetic dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • cosmetic adjuvants such as are conventionally used in such preparations, e.g. Preservatives, bactericides, perfumes, foaming inhibitors, colorants, pigments having a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moistening and / or moisturizing substances, fats, oils, waxes or other conventional ingredients of a cosmetic or cosmetic dermatological formulation such as alcohol
  • folic acid and / or its derivatives can also be combined with other antioxidants and / or radical scavengers.
  • the amount of antioxidants (one or more compounds) in the preparations is preferably from 0.001 to 30% by weight, particularly preferably from 0.05 to 20% by weight, in particular from 1 to 10% by weight, based on the total weight of the preparation ,
  • the lipid phase can advantageously be selected from the following substance group: mineral oils, mineral waxes
  • Oils such as triglycerides of capric or caprylic acid, furthermore natural oils, e.g. Castor oil;
  • Fats, waxes and other natural and synthetic fats preferably esters of fatty acids with lower C-number alcohols, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids; benzoates;
  • Silicone oils such as dimethylpolysiloxanes, diethylpolysiloxanes, diphenylpolysiloxanes and mixed forms thereof.
  • the oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions in the context of the present invention is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 carbon atoms and saturated and / or or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms.
  • ester oils can then advantageously be selected from the group isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2 Octyldodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate and also synthetic, semisynthetic and natural mixtures of such esters, eg jojoba oil.
  • the aqueous phase of the preparations according to the invention optionally advantageously contains alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or -mob nobutyl ether, propylene glycol monomethyl, -monoethyl- or -monobutylether , Diethylene glycol monomethyl or monoethyl ether and analogous products, furthermore lower C-number alcohols, eg Ethanol, isopropanol, 1, 2-propanediol, glycerol.
  • alcohols, diols or polyols of low C number, and their ethers preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or -mob nobutyl
  • mixtures of the abovementioned solvents are used.
  • alcoholic solvents water can be another ingredient.
  • Emulsions of the invention are advantageous and contain e.g. the said fats, oils, waxes and other fatty substances, as well as water and an emulsifier, as commonly used for such a type of formulation.
  • Gels according to the invention usually contain low-C alcohols, for example ethanol, isopropanol, 1,2-propanediol, glycerol and water or an abovementioned oil.
  • Suitable propellants for preparations which can be sprayed from aerosol containers according to the invention are the customary known highly volatile, liquefied propellants, for example carbonates. hydrocarbons (propane, butane, isobutane) suitable, which can be used alone or in combination with each other. Also, compressed air is advantageous to use.
  • preparations according to the invention may also contain substances which absorb UV radiation in the UVB range, the total amount of filter substances being e.g. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 10 wt .-%, in particular 1, 0 to 6.0 wt .-%, based on the total weight of the preparations to cosmetic preparations for To provide the hair or the skin against the entire range of ultraviolet radiation. They can also serve as a sunscreen for hair or skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne des préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de la 2-isopropyl-5-méthyl-cyclohexanecarbonyl-D-alanine et une ou plusieurs matières de charge.
PCT/EP2007/008236 2006-09-29 2007-09-21 Préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de l'acide (r)-2-[((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-propionique et une ou plusieurs matières de charge WO2008040463A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200610047160 DE102006047160A1 (de) 2006-09-29 2006-09-29 Kosmetische oder dermatologische Zubereitungen mit (R)-2-[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-propionsäure-methylester und einem oder mehreren Füllstoffen
DE102006047160.1 2006-09-29

Publications (1)

Publication Number Publication Date
WO2008040463A1 true WO2008040463A1 (fr) 2008-04-10

Family

ID=38920498

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/008236 WO2008040463A1 (fr) 2006-09-29 2007-09-21 Préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de l'acide (r)-2-[((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-propionique et une ou plusieurs matières de charge

Country Status (2)

Country Link
DE (1) DE102006047160A1 (fr)
WO (1) WO2008040463A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011078100A1 (de) * 2011-06-27 2012-12-27 Beiersdorf Ag Taptiokastärke in Silikonelastomer-haltigen kosmetischen Zubereitungen

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205255A1 (fr) * 1971-02-04 1972-11-30
WO2002032381A2 (fr) * 2000-10-10 2002-04-25 The Procter & Gamble Company Compositions cosmetiques emballees destinees au cuir chevelu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342560A1 (de) * 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
WO1997040031A1 (fr) * 1996-04-23 1997-10-30 Pharmacia & Upjohn Company Thiadiazolyl(thio)urees utiles comme inhibiteurs de metalloproteases a matrice
TW544310B (en) * 1998-04-02 2003-08-01 Ajinomoto Kk Amino acid derivatives and anti-inflammatory agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205255A1 (fr) * 1971-02-04 1972-11-30
WO2002032381A2 (fr) * 2000-10-10 2002-04-25 The Procter & Gamble Company Compositions cosmetiques emballees destinees au cuir chevelu

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WATSON H R ET AL: "NEW COMPOUNDS WITH THE MENTHOL COOLING EFFECT", JOURNAL OF THE SOCIETY COSMETIC CHEMISTS, SOCIETY OF COSMETIC CHEMISTS,, US, vol. 29, no. 4, 1978, pages 185 - 200, XP009045124, ISSN: 0037-9832 *

Also Published As

Publication number Publication date
DE102006047160A1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
US6511655B1 (en) Cosmetic or dermatological preparations of the oil-in-water type
DE60018179T2 (de) Silikongel enthaltend salizylsäure
JP3025436B2 (ja) 酸化チタン色素を含む化粧品及び/又は皮膚科用組成物の光青色化及び/または白色化を防止する変形可能な中空の粒子の使用
US8652447B2 (en) Cosmetic and personal care products containing synthetic magnesium alumino-silicate clays
CN104507444A (zh) 包含疏水气凝胶颗粒和二氧化硅颗粒的消光效果组合物
EP0695161A1 (fr) Preparations topiques cosmetiques et medicales
WO1997044009A1 (fr) Compositions cosmetiques ou pharmaceutiques a effet collant diminue
US5939079A (en) Process for the dispersion by high-pressure homogenization of pulverulent fillers in a vehicle composed of at least one fatty phase, compositions obtained and uses
CN104411286A (zh) 包含疏水气凝胶颗粒和珍珠岩颗粒的消光效果组合物
WO2008077728A2 (fr) Monocristal lamellaire de sulfate de baryum utilisé dans des compositions cosmétiques
WO2001005362A2 (fr) Systemes de type eau dans l'huile exempts d'emulsifiants et finement disperses
DE10036316A1 (de) Kosmetische Puderformulierungen
EP1094889A1 (fr) Preparations coulantes de type emulsion eau dans l'huile a teneur en eau augmentee
JP4757718B2 (ja) 皮膚バリア強化用の皮膚外用剤
WO2008040463A1 (fr) Préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de l'acide (r)-2-[((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-propionique et une ou plusieurs matières de charge
WO2008040462A1 (fr) Préparations cosmétiques ou dermatologiques comprenant de l'ester éthylique de l'acide (r)-2-[((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-propionique et une ou plusieurs matières de charge
JP2000212022A (ja) 化粧料
JP4939644B2 (ja) 紫外線吸収剤包接粘土鉱物及びこれを含有する化粧料
EP1882471A2 (fr) Préparation cosmétique comportant de l'acide folique et des composants parfumés
EP2046272A1 (fr) Préparations cosmétiques ou dermatologiques contenant de l'acide folique, des matières de charge et des épaississants
JP2010030933A (ja) 皮膚外用剤
EP1518533A2 (fr) Formulation cosmétique pulvérisable
DE10107628A1 (de) Kosmetische und dermatologische Zubereitungen in Form von W/O-Emulsionen mit einem Gehalt an Siliconölen und Talkum
JP2008013548A (ja) 粉末化粧料
EP2086499B1 (fr) Préparations cosmétiques ou dermatologiques comprenant de l'ester méthylique de la 2-isopropyl-5- methyl-cyclohexancarbonyl-d-alanine et un ou plusieurs agents d'hydratation de la peau

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07818326

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07818326

Country of ref document: EP

Kind code of ref document: A1